Search SciPol

Brought to you by
September
10

Comment Deadline: FDA Patient-Focused Drug Development on Chronic Pain

  • Government
  • Agency
  • Neuroscience

The Food and Drug Administration (FDA) is seeking comments on a meeting titled “Patient-Focused Drug Development for Chronic Pain.” The meeting will provide patients (including adult and pediatric patients) with an opportunity to present to FDA their perspectives on the impacts of chronic pain, views on treatment approaches for chronic pain, and challenges or barriers to accessing treatments.